Cases
Search
Statistics
Estimate
SEARCH
Show Filters
Decision Date
2020
(1)
2019
(1)
2017
(2)
2016
(1)
2015
(1)
Decision
Transfer
(6)
Complainant
Vivendi
(1)
JCDECAUX SA.
(1)
E. REMY MARTIN & Co.
(1)
Compagnie de Saint-Gobain
(1)
Boehringer Ingelheim International Gmbh.
(1)
BOEHRINGER Ingelheim Pharma GmbH & Co. KG
(1)
Respondent
域名管理35
(1)
Wengang Zhao, Suzhou Osealing Industrial Technology Co., Ltd.
(1)
Kelvin Baraka
(1)
Jin Shou Deng( 邓金寿)
(1)
Departement Juridique, Whois Privacy / Departement Juridique, Jcdecauxsa Departement Juridique
(1)
Data Protected Limited
(1)
Panelist
Sebastian M.W. Hughes
(6)
Complainant Country
France
(4)
Germany
(2)
Complainant Representative
Nameshield
(6)
Respondent Country
China
(4)
Taiwan
(1)
Russia
(1)
Respondent Reply
Yes
(2)
No
(4)
RDNH Status
No
(6)
Case Language
English
(6)
Case Particular
D
(6)
Number Of Domains
1
(6)
Domain Extension
网址
(1)
top
(1)
taipei
(1)
luxe
(1)
icu
(1)
group
(1)
Domain Extension Type
newgTLD
(6)
Domain Length
7
(3)
8
(1)
9
(1)
12
(1)
Includes Hyphen
Yes
(1)
No
(5)
Includes Number
No
(6)
Includes Letter
Yes
(5)
No
(1)
Domain Registrar
West263 International Limited
(1)
Net-Chinese Co., Ltd.
(1)
Internet Domain Name System Beijing Engineering Research Center LLC (ZDNS)
(1)
GuangDong NaiSiNiKe Information Technology Co Ltd.
(1)
Alibaba Cloud Computing Ltd. d/b/a HiChina (www.net.cn)
(1)
6
cases found.
Case Language: English
Case Particular: D
Complainant Representative: Nameshield
Decision: Transfer
Domain Extension Type: newgTLD
Includes Number: No
Panelist: Sebastian M.W. Hughes
Reset Search
giotrif.icu
Transfer
WIPO D2020-0759
(Decision Date: June 11, 2020)
vivendi.luxe
Transfer
WIPO D2019-1414
(Decision Date: Sept. 6, 2019)
jcdecaux.taipei
Transfer
WIPO D2017-2051
(Decision Date: Dec. 26, 2017)
saint-gobain.group
Transfer
WIPO D2017-1089
(Decision Date: Aug. 8, 2017)
spiriva.top
Transfer
WIPO D2016-0537
(Decision Date: May 24, 2016)
人头马.网址
Transfer
WIPO D2015-0038
(Decision Date: March 10, 2015)
Stay updated! Get new cases and decisions by daily email.
leave this field blank to prove your humanity
Subscribe
Scroll